Pareidolia for Traumatic Brain Injury
What You Need to Know Before You Apply
What is the purpose of this trial?
This study will investigate whether viewing and identifying meaningful shapes or images hidden within nature pictures (pareidolia) can improve motivation and engagement in rehabilitation therapy for adults with mild to moderate traumatic brain injury (TBI). Participants will be randomly assigned to either a pareidolia-based activity group or a control group and will complete therapy sessions and assessments over approximately three weeks. The findings may help identify a simple, low-risk approach to enhancing rehabilitation participation after TBI
Are You a Good Fit for This Trial?
This trial is for adults with mild to moderate traumatic brain injury who are currently in rehabilitation. People with severe injuries or other major health issues may not be eligible.Inclusion Criteria
Exclusion Criteria
What Are the Treatments Tested in This Trial?
Interventions
- Therapeutic Benefits of Pareidolia
Trial Overview
The study tests if looking for hidden shapes or images (pareidolia) in nature pictures can boost motivation and participation during rehab, compared to standard therapy. Participants are randomly placed into either the pareidolia group or a control group over three weeks.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Participants complete a structured pareidolia scavenger hunt involving identification of hidden images and shapes within nature-based pictures during rehabilitation sessions.
Participants complete a comparable walking and nature-image viewing activity without pareidolic images or instructions to search for hidden shapes.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Shirley Ryan AbilityLab
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.